Turn Therapeutics Inc.
TTRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023016
No open-market purchases or sales by Turn Therapeutics Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $8.48M in total; no superinvestor holds it.
Holders of 5% or more of TTRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Turn Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Burnam Bradley Evan | 13G | 52.76%15.7M shares | New | Apr 6, 20261 filing | Apr 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Turn Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 6, 20268:05 AM ET | Burnam Bradley Evan | 13G | 52.76%15.7M shares | New | Dec 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Turn Therapeutics Inc. shares.
No Form 144 notices for Turn Therapeutics Inc. are on file.